858-449-1310 contact@somatek.com

BLOG

Monoclonals for migraine

Exciting news regarding a new indication for monoclonal antibodies. FDA has approved Aimovig, a product of the Amgen and Novartis Neuroscience Collaboration, for the prevention of frequent, debilitating migraines.  Aimovig is a human immunoglobulin G2 monoclonal...

read more

Mark Fitchmun visits Infors HT

Somatek is increasing its upstream capabilities to serve the needs of existing and future clients. The objective is to support research scale and manufacturing scale upstream processes and integrate those with Somatek’s establish core strengths in downstream and assay...

read more

Monoclonals for dogs

If your dog needs itch relief, your vet may now offer a drug called Cytopoint. Cytopoint, produced by Zoetis Inc. and available in the US since early 2018, is an engineered (caninized) monoclonal antibody directed against interleukin-31. Interleukin-31 has been shown...

read more

CAR-T Cells: Cool new poster

Got empty wall space in your lab or hallway? Consider decorating with the new timely “Chimeric Antigen Receptor (CAR)-T Cell in Immunotherapy” poster available from Novus Biologicals.  https://www.novusbio.com This wall poster provides an overview of Chimeric Antigen...

read more

A novel recombinant protein for treatment of stroke

Stroke is the fifth leading cause of death in the United States and the number one cause of adult disability. Acute ischemic strokes occur when a clot blocks blood flow to the brain. To date, the FDA has approved only one drug treatment, called tissue plasminogen...

read more

FDA’s Top Ten Drug GMP Citations

At the FDA/Xavier University PharmaLink conference at Xavier University in Cincinnati, Ohio, in March 2017, FDA's Robert Tollefsen and Dell Moller presented the top ten drug GMP inspection citations for FY 2016. As summarized by Elanco's Brent Conatser these citations...

read more